Precision Optics Corporation, Inc.
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Joseph N. Forkey
- Full Time Employees
- 83
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- 22 East Broadway Gardner MA United States of America 01440
- IPO Date
- Jan 16, 1992
- CIK
- 0000867840
- Website
- poci.com
- Similar Companies
- Business
- Precision Optics Corporation, Inc. (Nasdaq: POCI) designs, develops, manufactures and sells advanced optical systems, illumination components and related assemblies primarily for medical instrumentation, defense/aerospace and industrial applications; core products include specialty endoscopes, micro endoscopes, CMOS endoscopes, endocouplers, microprecision lenses down to 0.37 millimeters, micro prisms to 0.10 millimeters, micro medical cameras, 3D endoscopes for minimally invasive surgery and robotic systems, as well as custom imaging systems, opto-mechanical subassemblies and components for satellite communications and high-precision defense uses. Founded in 1982 and headquartered in Gardner, Massachusetts, with additional divisions in Maine and Texas, the company serves healthcare equipment manufacturers, hospitals, physicians, top-tier aerospace firms and military customers principally in the United States and global markets. Recent developments include a Main Purchase Agreement in April 2025 with a leading aerospace customer that expanded its program backlog to $6.6 million, providing production visibility through 2026; a $5.1 million registered direct common stock offering in February 2025 to reduce debt and fund facility expansions for medical and defense growth; and ongoing investments in micro-optics capabilities to support next-generation disposable devices and 3D visualization technologies.
Precision Optics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
Precision Optics Corporation, Inc. (POCI) Q3 2026 Earnings Call Transcript
Precision Optics Reports Third Quarter Fiscal Year 2026 Financial Results
Precision Optics Schedules Third Quarter of Fiscal Year 2026 Conference Call for May 13, 2026
Precision Optics Announces Receipt of $3.5 Million Follow-On Production Order for Single-Use Ophthalmic Program
Precision Optics Corporation, Inc. Announces Proposed Public Offering of Common Stock
Precision Optics Q2 Earnings Call Highlights
Precision Optics Corporation, Inc. (POCI) Q2 2026 Earnings Call Transcript
Precision Optics Schedules Second Quarter of Fiscal Year 2026 Conference Call for February 17, 2026
Financial Contrast: Imris (OTCMKTS:IMRSQ) versus Precision Optics (NASDAQ:POCI)
OrthoPediatrics (NASDAQ:KIDS) vs. Precision Optics (NASDAQ:POCI) Financial Survey
Precision Optics Corporation, Inc. (POCI) Q1 2026 Earnings Call Transcript
Precision Optics Reports First Quarter Fiscal Year 2026 Financial Results
Precision Optics Announces Product Development Agreement to Develop Custom High-End Borescope for Jet Engines
Precision Optics Announces Product Development Agreement to Deliver Next-Generation Augmented Reality Sub-Systems for Fighter Pilots
Precision Optics Schedules First Quarter of Fiscal Year 2026 Conference Call for November 13, 2025
Precision Optics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
Precision Optics Corporation, Inc. (POCI) Q4 2025 Earnings Call Transcript
Precision Optics Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Precision Optics Schedules Fourth Quarter and Fiscal Year 2025 Conference Call for September 29, 2025